Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 20 to 60

Comparing recovery methods after laparoscopic sleeve gastrectomy

Official title: Quality of Recovery in Laparoscopic Sleeve Gastrectomy Using Dexmedetomidine Infusion Versus Laparoscopic TAP Block in Combination With Paragastric Neural Block

Run by Alexandria University · NCT06970626 · Data updated 2026-11-12

This study is testing which recovery method works better for people with obesity after laparoscopic sleeve gastrectomy by comparing two different pain management techniques.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages20 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorAlexandria University
Academic / other
Locations1 site (Alexandria)
StatusRecruiting
StartedApril 3, 2025
Main results expectedJune 4, 2025
Study endsJune 20, 2025
Registry record updatedMay 14, 2025
Trial IDNCT06970626 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients with a BMI between 35 and 50 kg/m2 and classified as ASA physical status II-III.

Probably not a fit

Patients with significant hepatic, renal, neuromuscular, or cardiac impairments, extreme obesity (BMI > 50 kg/m2), or those currently on opioid medication may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine which recovery method is more effective for patients undergoing laparoscopic sleeve gastrectomy: a combination of dexmedetomidine infusion and paragastric neural block or a combination of laparoscopic TAP block and paragastric neural block. The study will evaluate recovery by measuring opioid consumption, hemodynamic stability, pain scores, quality of postoperative recovery, and incidence of nausea or vomiting. It involves patients with a BMI of 35-50 kg/m2 and ASA physical status II-III, assessing their recovery outcomes post-surgery.

Why it matters

Potential benefit: If successful, this study could lead to improved recovery protocols for patients undergoing laparoscopic sleeve gastrectomy, potentially reducing pain and opioid use.

How similar studies have gone: Other studies have shown promising results with similar approaches in enhancing recovery after surgical procedures, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. American Society of Anesthesiologists (ASA) physical status II- III
2. BMI 35- 50 kg/m2

Exclusion Criteria:

1. Significant hepatic, renal, neuromuscular, or cardiac impairments
2. Extreme obesity (BMI \> 50 kg/m2)
3. Patients on current opioid medication
4. Allergies to dexmedetomidine or bupivacaine

Where it's running

  • Alexandria Main University Hospital
    Alexandria, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.